Acucela Inc.: Detailed Company Information & Corporate Profile
Summary
Acucela Inc., established in 2002, is a Seattle‑based biotech company specializing in ophthalmology solutions and operating within the $10M–$50M revenue bracket.
With a workforce of 10–50 employees, the company leverages cutting‑edge research to develop ocular therapeutics, contributing to advances in eye care.
Leadership includes Chairman, President & CEO Ryo Kubota; Communications Coordinator Tomoko Sato Miles; Senior Scientist Michael Reid and Principal Scientist Rad Tzekov; Clinical Trial Manager Angie Muller; Director of Clinical Development & Medical Affairs Brett OConnor; Director of Financial Planning Analysis Robert Merikle; Senior Manager Contracts and Purchasing Tracy Davis; and Board member Peter Kresel.
| Acucela Inc. Website | acucela.com |
| Industries | |
| Acucela Inc. Headquarters Address | 818 Stewart Street, Seattle, WA, 98101 US |
| Company Size | 10-50 employees |
| Specialities & Services | Ophthalmology |
| Founded | 2002 |
| Estimated Annual Revenue | $10M - 50M |
| Updated: | 2026-09-23 |
Workforce Turnover
Length of Employment
Acucela Inc.'s workforce includes employees across a wide range of tenure levels.
6% have been with the company for 5 to 7 years25% have been with the company for 8 to 10 years69% have been with the company for more than 11 years
Companies Similar to Acucela Inc.
Acucela Inc. Corporate Information: FAQ
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
